Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2022, Vol. 27 ›› Issue (2): 227-234.doi: 10.12092/j.issn.1009-2501.2022.02.015

Previous Articles     Next Articles

Ferroptosis regulatory signaling pathway and its research progress in related diseases

ZHANG Liang1,2, LIAO Yongqun3, XIA Qinchuan3, ZHOU Shitong4, LI Xiaoli1,2   

  1. 1Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing 400016, China; 2Chongqing Key Laboratory of Drug Metabolism, Chongqing 400016, China; 3Fuan Pharmaceutical Group Chongqing Bosen Pharmaceutical CO.LTD, Chongqing 401221, China; 4Department of Otolaryngology Head and Neck Surgery, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing 400014, China 
  • Received:2021-09-02 Revised:2022-01-25 Online:2022-02-26 Published:2022-03-09

Abstract: Ferroptosis is an iron-dependent novel type of programmed cell death. The main features of ferroptosis include lipid reactive oxygen accumulation, iron accumulation and lipid peroxidation. The main mechanisms and signal pathways of ferroptosis are complex and closely related to cystine/glutamate antiporter system, glutathione peroxidase 4, ferroptosis suppressor protein 1, and dihydroorotate dehydrogenase. This review summarizes the current regulatory mechanisms of ferroptosis and discusses the research progress of ferroptosis in tumors, non-alcoholic fatty liver disease, Parkinson's disease, and congestive heart failure.

Key words: ferroptosis, iron metabolism, lipid peroxidation, cancer, non-alcoholic fatty liver disease

CLC Number: